Gerry Brunk

Baxter is committed to helping you save and sustain lives. Our diagnostic cardiology products support you in gaining accurate information about abnormal rhythm events to help you diagnose and treat patients with confidence. From resting electrocardiogram (ECG) to diagnostic stress testing to continuous ambulatory cardiac monitoring, we are innovating to provide you diagnostic accuracy and cost-effective solutions that help deliver care without compromise.

Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.

Baxter is committed to helping you save and sustain lives. Our diagnostic cardiology products support you in gaining accurate information about abnormal rhythm events to help you diagnose and treat patients with confidence. From resting electrocardiogram (ECG) to diagnostic stress testing to continuous ambulatory cardiac monitoring, we are innovating to provide you diagnostic accuracy and cost-effective solutions that help deliver care without compromise.

Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.

The Licensing & Ventures Group is the University of Virginia intellectual property management and innovation commercialization organization for UVA’s research portfolio (lvg.virginia.edu). Founded in 1977 as a 501(c)(3) UVA affiliated foundation, UVA LVG receives ~200 invention disclosures, executes ~80 commercial transactions, and launches 5-7 new companies each year. Our mission as an organization is to maximize the intellectual, societal, and economic impact of UVA discoveries via commercialization to enrich and improve lives for the University, the Commonwealth, and the world.

Lumira Ventures is a leading healthcare and life sciences venture capital firm, investing in innovative entrepreneurs developing best and first-in-class therapeutics & medical technologies across North America. We are engaged partners who support the management teams of companies we invest in to build products that have the potential to allow people to lead fundamentally healthier, longer, and more productive lives.

Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact. Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, fueled by the goal of helping our clients thrive and enabling them to make the world a better place. BCG Privacy Policy: https://www.bcg.com/about/privacy-policy.aspx